Literature DB >> 20658965

Cell cycle events mediate lactacystin-induced apoptotic death of neuronal PC12 cells.

Zhentao Zhang1, Yan Xu, Kairong Qin, Tao Wang, Xuebing Cao.   

Abstract

Dysfunction of the UPS (ubiquitin-proteasome system) has been implicated in dopaminergic neuronal death in PD (Parkinson's disease). Recent studies suggest that unregulated cell cycle events play a key role in neuronal death. In this study, the effects of UPS dysfunction on cell cycle events in neuronal differentiated PC12 cells were analysed using a specific inhibitor of proteasome, lactacystin. Lactacystin induced apoptosis, G₂/M cell cycle arrest and sustained the phosphorylation of the pRB (retinoblastoma protein), the key molecular process of G₁/S transition, in neuronal PC12 cells. Furthermore, inhibition of cell cycle progression protected against lactacystin-induced cell apoptosis. Finally, we determined that lactacystin activated the ERK signalling pathway. Inhibition of ERK1/2 activation by MEK-1 inhibitor PD98059 decreased cell cycle aberrant and prevented apoptosis induced by lactacystin. These results indicate that aberrant cell cycle events contribute to apoptotic death induced by UPS dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658965     DOI: 10.1042/CBI20090079

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  2 in total

1.  2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.

Authors:  Jianyi Niu; Jing Xiong; Dan Hu; Fei Zeng; Shuke Nie; Shanping Mao; Tao Wang; Zhentao Zhang; Zhaohui Zhang
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

2.  Proliferating cell nuclear antigen binds DNA polymerase-β and mediates 1-methyl-4-phenylpyridinium-induced neuronal death.

Authors:  Zhentao Zhang; Zhaohui Zhang; Hongcai Wang; Guoxin Zhang; Dan Hu; Jing Xiong; Nian Xiong; Tao Wang; Xuebing Cao; Ling Mao
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.